Wisdom Pharmaceutical announced that the company recently received the “Approval to Register Issuance of Shares to Specific Targets” issued by the China Securities Regulatory Commission, agreeing to the company's registration application to issue shares to specific targets. The approval is valid for 12 months from the date of consent to registration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.